New Treatment for Alzheimer’s and Huntington’s Diseases Relies on Addressing the Beta-Amyloid Pathway.

Comments by J. C. Spencer

Ridding the brain of toxic amyloid plaques is viewed as a key target in slowing the course of Alzheimer's disease.  The amyloid pathway is THE MAIN HALLMARK OF ALZHEIMER'S DISEASE.  Here are two articles that deal with Alzheimer’s, Huntington’s, and the beta-amyloid pathway.  WHATEVER WORKS is what families with Alzheimer’s or Huntington’s members want to see.  Research has concluded what the problem is.  Throwing billions of dollars at the problem may not be the solution, but scientists are trying.  Part of the problem is that every drug, regardless of the hope it may help, adds more toxins to the body. 

Meanwhile, I suggest we look further at cutting healthcare costs by switching out regular sugar with a glyconutrient called trehalose.  The first article below is about GSK paying $28.5 million up front for a vaccine deal that may held address the beta-amyloid challenge.  The second article is an abstract from a published paper showing that the sugar trehalose may hold the answer for Alzheimer’s and Huntington’s disease by addressing the beta-amyloid challenge.

DIABETES and the Sugar Trehalose
The Sugar Trehalose is helping Diabetics

Comments by J. C. Spencer

Recently, I have personally received a number of calls from diabetic who are having great results using trehalose as their sweetener. Some diabetics tell me that when they stop using trehalose that their sugar load goes back up. As long as they are eating the healthful sugar trehalose - their sugar load is normal.

Now, let me be the first to say that just because trehalose works for one diabetic does not mean it will work for every diabetic. Each of us have unique body chemistry. While no medical claims are made, it is exciting to hear from so many diabetics that are having outstanding results.

Every diabetic should continue to monitor their blood sugar daily while eating trehalose on their cereal or in their tea or coffee.

To help us gather more data, please download the Diabetic Nutritional Pilot Survey Forms from the left side of our Home Page.

News from The Endowment for Medical Research, Inc.

Today The Endowment introduces a new service of great value and benefit to our friends... our Affiliate Program.  The Affiliate Program gives you greater leverage to educate others about Glycomics.  You have the tools through our website to educate others in Glycomics, the science of sugars, and now YOU CAN BE REWARDED FOR EDUCATING OTHERS.

The Affiliate Program is FREE but an Affiliate must be Certified.  As a Certified Affiliate, you can send your friends and contacts to The Endowment website through your personalized encrypted link/banner on your website, in your blog, or at the bottom of your e-mails. 

You will be protected and automatically notified when anyone comes to The Endowment website through your link, to purchase anything in our Store Front or request more information.  It is simple... check out our Affiliate Program and earn while you and others learn.

Click on the Affiliate Program link and learn how you can benefit from Sharing the Sugar Story starting today. 

J. C. Spencer

The Sugar Trehalose is a Healthful Replacement for MSG

Comments by J. C. Spencer

A small amount of the sugar trehalose can be used to enhance the flavor of foods in a healthful way. MSG is widely used to make foods more flavorful but MSG has serious side effects including possible inflammation, obesity, diabetes, autoimmune diseases and liver disease. MSG can induce neuronal death. MSG may have contributed more damage to neurodegenerative diseases than we previously thought. But now, a pinch of trehalose is not only a fabulous replacement for MSG but appears to be one of the best brain foods available.

Here are three Abstracts from recently published papers on monosodium glutamate (MSG).

August 19, 2008 - Houston, Texas

In an effort to better inform healthcare professionals and the general public about the science of sugars, The Endowment for Medical Research announced today that it is releasing three Glycomics Educational Training Kits. Most healthcare professionals are still unaware of the science although there are over 465,000 references to glycoproteins on the NIH sponsored website at www.pubmed.gov/ and MIT said it is one of the technologies that will change the way we live.

Details about the doctors and professors in the Training Kits can be found online at www.endowmentmed.org/ Participants are able to acquire fourteen hours of glycomics training on a first come first served basis.

The Endowment for Medical Research, Inc is a 501(c)(3) non-profit educational and scientific research public charity located in Houston, Texas.

First in a series starting with MANNOSE with the understanding that research indicates they work synergistically when eaten together.

by J. C. Spencer

The knowledge of glycomics, the study of sugars, is growing exponentially.  The National Library of Medicine sponsored by the National Institutes of Health (NIH) on their website www.PubMed.gov cites 465,656 references (as of this writing) to published papers on glycoprotein.  Scientists are adding so many new research papers each day (thousands per month) that it is nearly impossible for anyone to keep up with the progress of glycomics.  PubMed references to published papers on one of the nine sugars, mannose, is already at 21,306.